Back to search

Article

Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment

2020-12-14

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Metastatic castrate-resistant prostate cancer (CRPC) remains uncurable and novel therapies are needed to better treat patients. Aberrant Fibroblast Growth Factor Receptor (FGFR) signaling has been implicated in advanced prostate cancer (PCa), and FGFR1 is suggested to be a promising therapeutic target along with current androgen deprivation therapy. <h4>Methods</h4> We esta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
430b441a-41f2-5de7-b67e-a10dd78530f5
DOI
10.1101/2020.12.13.422586
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatmentDOI 10.1101/2020.12.13.422586
Select a neighboring publication to make it the new centre.